Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health Anxiety

LSD-assisted therapy induces rapid and lasting reductions in anxiety and depression symptoms, according to new research

by Eric W. Dolan
September 8, 2022
in Anxiety, LSD
(Photo credit: InkaChill)

(Photo credit: InkaChill)

Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

LSD-assisted therapy could provide benefits to patients struggling with anxiety disorders, according to new research published in Biological Psychiatry. The findings suggest that the psychedelic drug can produce notable reductions of anxiety and comorbid depression symptoms.

LSD-assisted therapy involves the controlled administration of lysergic acid diethylamide under the guidance of a trained therapist. Although LSD is best known as a recreational drug, some research suggests that it can have powerful therapeutic effects in a wide range of psychiatric conditions when combined with psychotherapy.

The findings from the new research provide preliminary evidence that LSD-assisted therapy can result in long-term reductions in anxiety symptoms. “The response was surprisingly sustained,” said study author Matthias Liechti, a professor of clinical pharmacology at University Hospital Basel.

A small pilot study had already found evidence that LSD-assisted therapy could help reduce anxiety symptoms in patients with life-threatening illness. The new double-blind, placebo-controlled study sought to corroborate these findings in patients with anxiety with and also without a life-threatening illness.

“Primarily, we wanted to confirm a pilot study on the effects of LSD in patients with anxiety and life-threatening illness,” Liechti explained. “Secondly, we also wanted to explore therapeutic benefits in patients with an anxiety disorder such as general anxiety disorder and without the somatic illness. Furthermore, we wanted to use LSD instead of psilocybin, which is more commonly used in modern psychedelic research, to broaden the field.”

The study included 20 participants who had a life-threatening somatic illness (such as a diagnosis of cancer) and 22 participants with an anxiety disorder that was not associated with a somatic illness. Psychiatric symptoms were assessed with the Spielberger’s State-Trait Anxiety Inventory, the Hamilton Depression scale, the Beck Depression Inventory, and the Symptom-Check-List-90-R — scientifically-validated questionnaires that are widely used both in clinical settings and in research.

Each participant underwent an initial screening visit and two 24-week treatment periods. The study employed a crossover design, meaning that the participants were randomly assigned to receive either LSD or placebo in the first treatment period and vice versa in the second treatment period. The participants 200 μg of LSD, a relatively high dose.

The researchers found that LSD produced strong reductions in anxiety, depression, and general psychiatric symptomatology compared with placebo. These reductions were still observed 16 weeks after the last LSD treatment.

“LSD may have therapeutic benefits in anxiety disorders and also reduce depression,” Liechti told PsyPost. “The therapeutic effects set in fast and were sustained up to 16 weeks following the treatment with two single doses of LSD.”

The researchers also found evidence that some of the specific subjective effects of LSD were linked to reductions in anxiety. In particular, participants who reported greater feelings of oceanic boundlessness, which is characterized by a feeling of oneness with the world, were more likely to experience long-term reductions in anxiety symptoms. The same was true for participants who scored high on a measure of mystical experiences.

“LSD was overall well tolerated,” Liechti noted. During the entire study, a total of nine serious adverse events occurred. Six of these events occurred during the LSD treatment period.

But only one serious adverse event was considered related to treatment, according to the researchers. A patient experiencing anxiety and delusions during an LSD session was treated with lorazepam and olanzapine. “The patient was kept overnight and discharged in the morning and experienced no further long-term symptoms.”

While the initial results are promising, Liechti said that “more studies are needed to confirm these effects.” The issue of unblinding has been raised as a concern for psychedelic research. Because of the powerful subjective effects of LSD, it’s easy for participants to determine whether they’ve received the substance or a placebo.

“The blinding of the acute effects of psychedelics is not possible against a placebo,” Liechti said. “Future studies may therefore include different doses and show a dose-response effect instead.”

The study, “Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness: A randomized, double-blind, placebo-controlled Phase II study“, was authored by Friederike Holze, Peter Gasser, Felix Müller, Patrick C. Dolder, and Matthias E. Liechti.

TweetSendScanShareSendPin4ShareShareShareShareShare

RELATED

Liver health may influence mental health via inflammation and glutamate levels
Anxiety

Liver health may influence mental health via inflammation and glutamate levels

June 28, 2025

A new study suggests that diets high in fat and fructose can damage the liver and trigger anxiety-like behaviors in mice. The research also found that corilagin, a natural compound, reversed many of these harmful effects.

Read moreDetails
How people end romantic relationships: New study pinpoints three common break up strategies
Anxiety

Spider fear inflates size perception, highlighting the role of emotion in threat assessment

June 26, 2025

A new study finds that people afraid of spiders perceive them as larger than they really are, while arachnology experts judge their size accurately. The findings shed light on how emotion and knowledge shape perception of threatening creatures.

Read moreDetails
Anxious minds don’t always fixate on danger, according to new study
Anxiety

Anxious minds don’t always fixate on danger, according to new study

June 25, 2025

A new study challenges long‑held ideas about anxiety and attention. It finds that when motivated, anxious people can shift focus from threats just as quickly as others — suggesting that “dwelling” on threats may be more about circumstance than an inherent deficit.

Read moreDetails
Indirect exposure to gun violence linked to reduced quality of life in four different domains
Anxiety

Economic data reveal the disturbing “echo of anxiety” after fatal school shootings

June 25, 2025

A new study finds that fatal school shootings have lasting economic impacts far beyond the tragedy itself. Fear and anxiety ripple through communities, leading people to spend less on groceries, restaurants, and other public spaces for months after the shooting.

Read moreDetails
Self-compassion training and relaxation training are equally effective at reducing social anxiety symptoms, study finds
Anxiety

Anxiety and anger may explain how parenting styles shape life satisfaction

June 21, 2025

Parental bonding may influence happiness well into adulthood, according to a new study. Italian researchers found that overprotective parenting predicted greater anxiety, while caring parenting supported healthier anger control—both of which played roles in shaping overall life satisfaction.

Read moreDetails
Borderline personality and depression: New findings show gender differences in adolescents
Anxiety

New research links heatwaves to depression and anxiety in adolescents, with some at higher risk

June 19, 2025

A new study finds that teens exposed to stronger heatwaves are more likely to experience mental health symptoms, raising concerns about the psychological impact of climate change on youth.

Read moreDetails
Brain chemistry imbalance revealed in violent offenders with antisocial personality disorder
LSD

Flipping two atoms in LSD turned it into a powerful treatment for damaged brain circuits

June 13, 2025

A new study introduces JRT, a modified version of LSD that promotes brain cell growth without triggering hallucinations. Researchers say this non-hallucinogenic compound could offer safer treatment options for schizophrenia and related brain disorders where psychedelics are typically contraindicated.

Read moreDetails
Anxious-depressed individuals underestimate themselves even when they’re right
Anxiety

Anxious-depressed individuals underestimate themselves even when they’re right

June 8, 2025

New research reveals that individuals with symptoms of anxiety and depression struggle to integrate their own moments of confidence into broader self-assessments. This internal bias, rather than poor performance, may drive persistent underconfidence in everyday life.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Ketogenic diet raises brain blood flow by 22% and BDNF by 47% in new study

Small folds in the brain may hold key insights into Alzheimer’s and aging-related cognitive decline

New research suggests interparental conflict can spill over into a mother’s parenting style

Creativity in autism may stem from co-occurring ADHD, not autism itself

Cannabis oil might help with drug-resistant epilepsy, study suggests

New brain stimulation method shows promise for treating mood, anxiety, and trauma disorders

Peppermint tea boosts memory and attention—but why?

Psychedelic compound blurs boundary between self and others in the brain, study finds

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy